Xcout Intel
Kriya Therapeutics competitors & alternatives
The 12 closest competitors and alternatives to Kriya Therapeutics among biotechnology companies — ranked by similarity to what Kriya Therapeutics actually does, not by market-cap band.
Subscribe to see Kriya Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Kriya Therapeutics
Kriya Therapeutics, Inc. is a fully integrated biopharmaceutical company with operational footprints in Redwood City, California, and Research Triangle Park, North Carolina. The company develops novel gene therapies to address diverse diseases.
Kriya Therapeutics at a glance
Kriya Therapeutics is a biotechnology company headquartered in United States. It has raised at least $957.1M across the 5 funding rounds on record. Its most recent funding round, Series D, raised $320M in September 2025. Xcout tracks 33 named people at Kriya Therapeutics, including Shankar Ramaswamy (Chief Executive Officer). Xcout recorded 2 job postings from Kriya Therapeutics in the last 90 days.
Kriya Therapeutics leadership
- Shankar RamaswamyChief Executive Officer
- Mark ChenChief Operating Officer
- Sachiyo MinegishiChief Financial Officer
- Brian FurmanskiChief Development Officer
- Britt PettyChief Manufacturing Officer
- Greg Di RussoChief Medical Officer
27 more named people on record for Kriya Therapeutics, with roles, board committees and tenure — see the full roster →
Kriya Therapeutics funding rounds
At least $957.1M raised across the 5 rounds on record. The 3 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series D | $320M | 5 named | |
| SEC Form D filing | $361.8M | — | |
| Seed | $100M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at Kriya Therapeutics
Xcout recorded 2 job postings from Kriya Therapeutics in the last 90 days, from a hiring record Xcout has kept since July 2026.
The weekly hiring trend, the roles and locations behind it — see Kriya Therapeutics's hiring signals →
Top 12 Kriya Therapeutics competitors
Ranked by semantic similarity — how close each company is to Kriya Therapeutics by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Life Science
ReCode Therapeutics is a clinical-stage genetic medicines company headquartered in Menlo Park, California, and Durham, North Carolina. The company leverages proprietary delivery systems to power a new class of disease-modifying genetic therapies.
Similar biotechnology company
Atsena Therapeutics, Inc. is a clinical-stage gene therapy company headquartered in Durham, North Carolina, established in 2019. The firm focuses on developing novel gene therapies to treat debilitating inherited blinding diseases using proprietary vector delivery technologies. Its scientific pipeline aims to address areas of high unmet medical need in ophthalmology.
Biotech
Encoded Therapeutics is a biotechnology company headquartered in South San Francisco, California, dedicated to developing next-generation genetic medicines designed to address the root causes of genetic diseases.
Biotech
Adverum Biotechnologies is a clinical-stage biotechnology research company headquartered in Redwood City, California. The company focuses on developing novel gene therapies designed to redefine ocular care and treat severe eye diseases.
Similar biotechnology company
Gemma Labs Inc. (GEMMABio) is a biotechnology company that develops gene therapies for rare diseases using next-generation AAV technology. The company focuses on programs targeting motor neuron disorders, skeletal conditions, and cardiomyopathies to serve the rare disease community.
Similar biotechnology company
Ray Therapeutics, Inc. is a privately held optogenetic gene therapy company headquartered in Berkeley, California. The company focuses on reimagining vision through innovative genetic treatments and novel therapeutic solutions.
Biotech
Korro Bio, Inc., a biopharmaceutical firm based in Cambridge, Massachusetts, is dedicated to exploring, advancing, and bringing to market genetic therapeutics. These treatments are formulated through RNA editing technology, aiming to address a wide array of medical conditions, encompassing both uncommon and widespread diseases.
Similar biotechnology company
4D Molecular Therapeutics, Inc. is a clinical-stage gene therapy company that engineers therapeutic agents by leveraging its proprietary adeno-associated virus (AAV) vector technology. The company's developmental efforts are concentrated across a trio of therapeutic fields: ophthalmology (eye conditions), cardiology (heart ailments), and pulmonology (respiratory disorders). Within its active pipeline, three specific product candidates have advanced into clinical trial phases, all currently undergoing Phase 1/2 clinical assessment: 4D-125 is being evaluated for the treatment of X-linked retinitis pigmentosa. 4D-110 targets choroideremia. 4D-310 is focused on addressing Fabry disease. Beyond these, two Investigational New Drug (IND) candidates are in development: 4D-150, aimed at combating wet age-related macular degeneration, and 4D-710, designed to tackle cystic fibrosis lung disease. To advance its mission, 4D Molecular Therapeutics, Inc. actively engages in research and development partnerships with entities such as uniQure, CRF, Roche, and CFF. The firm commenced operations in 2013 and maintains its headquarters in Emeryville, California.
Biotech
Rejuvenate Bio, Inc. is a biotechnology company founded in 2019 and headquartered in San Diego, United States, specializing in innovative gene therapy applications.
Similar biotechnology company
Kelonia Therapeutics, Inc. is a clinical-stage biotech company headquartered in Boston, Massachusetts, focused on delivering genetic medicine for patients.
Similar biotechnology company
AskBio is a clinical-stage gene therapy company that develops adeno-associated virus (AAV) gene therapies to treat genetic and complex disorders. The company focuses on advancing genetic medicine through its proprietary technology platforms, manufacturing processes, and clinical trials.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Kriya Therapeutics and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Kriya Therapeuticsand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →